Merck Free Cash Flow 2010-2024 | MKKGY
Merck annual/quarterly free cash flow history and growth rate from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Merck free cash flow for the quarter ending June 30, 2024 was 1,156.59, a year-over-year.
- Merck free cash flow for the twelve months ending June 30, 2024 was , a year-over-year.
- Merck annual free cash flow for 2023 was $2.16B, a 52.09% decline from 2022.
- Merck annual free cash flow for 2022 was $4.509B, a 7.16% increase from 2021.
- Merck annual free cash flow for 2021 was $4.208B, a 75.51% increase from 2020.
| Merck Annual Free Cash Flow |
| 2023 |
2,160.27 |
| 2022 |
4,509.41 |
| 2021 |
4,208.29 |
| 2020 |
2,397.69 |
| 2019 |
2,322.88 |
| 2018 |
1,582.54 |
| 2017 |
2,058.28 |
| 2016 |
2,017.33 |
| 2015 |
1,875.62 |
| 2014 |
2,975.77 |
| 2013 |
2,415.52 |
| 2012 |
2,756.24 |
| 2011 |
|
| 2010 |
|
| 2009 |
|
| Merck Quarterly Free Cash Flow |
| 2024-06-30 |
1,156.59 |
| 2024-03-31 |
567.82 |
| 2023-12-31 |
2,160.27 |
| 2023-09-30 |
1,581.45 |
| 2023-06-30 |
676.05 |
| 2023-03-31 |
312.36 |
| 2022-12-31 |
4,509.41 |
| 2022-09-30 |
2,208.79 |
| 2022-06-30 |
1,090.81 |
| 2022-03-31 |
479.18 |
| 2021-12-31 |
4,208.29 |
| 2021-09-30 |
3,196.81 |
| 2021-06-30 |
1,854.34 |
| 2021-03-31 |
1,093.48 |
| 2020-12-31 |
2,397.69 |
| 2020-09-30 |
1,659.98 |
| 2020-06-30 |
537.34 |
| 2020-03-31 |
196.37 |
| 2019-12-31 |
2,322.88 |
| 2019-09-30 |
1,784.76 |
| 2019-06-30 |
975.30 |
| 2019-03-31 |
325.98 |
| 2018-12-31 |
1,582.54 |
| 2018-09-30 |
1,033.64 |
| 2018-06-30 |
435.30 |
| 2018-03-31 |
199.13 |
| 2017-12-31 |
2,058.28 |
| 2017-09-30 |
1,768.83 |
| 2017-06-30 |
1,036.11 |
| 2017-03-31 |
631.96 |
| 2016-12-31 |
2,017.33 |
| 2016-09-30 |
1,435.18 |
| 2016-06-30 |
439.41 |
| 2016-03-31 |
218.43 |
| 2015-12-31 |
1,875.61 |
| 2015-09-30 |
1,317.10 |
| 2015-06-30 |
486.40 |
| 2015-03-31 |
232.74 |
| 2014-12-31 |
2,975.77 |
| 2014-09-30 |
1,725.76 |
| 2014-06-30 |
960.26 |
| 2014-03-31 |
561.21 |
| 2013-12-31 |
2,415.52 |
| 2013-09-30 |
2,053.02 |
| 2013-06-30 |
1,046.03 |
| 2013-03-31 |
631.65 |
| 2012-12-31 |
2,756.24 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
599.05 |
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.254B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
